Methods and compositions for treating and preventing posterior segment ophthalmic disorders
CA 2373237 A1 · Owner: Insite Vision Incorporated · Inventors: Rowe-Rendleman, Cheryl; Roy, Samir; Bowman, Lyle M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and compositions for the prophylactic and therapeutic treatment of ophthalmic disorders associated with the posterior segment of the eye using topical ophthalmic compositions comprising therapeutic agents. The invention specifically provides for methods and compositions for the prophylactic and therapeutic treatment of retinal disorders associated with neovascularization using topical ophthalmic compositions comprising hydroxamic acid matrix metalloproteinase inhibitors such as batimastat.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 7, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 7, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 7, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.